Dykema (Cannabis Law Blog)

JANUARY 21, 2022

As the Michigan cannabis industry continues to grow and mature, medical and adult-use licensees would be well served to take proactive steps to ensure compliance with Environmental, Health and Safety (EHS) regulations. Indeed, in November 2021, the MRA sent a voluntary survey to licensed processors across the State of Michigan.

Compliance 95

Compliance Compliance Safety Programs 95

SpeedWeed

FEBRUARY 21, 2021

February 18, 2021. | The post Cannabis mixtures studied as treatment for COVID inflammation appeared first on SpeedWeed. Published. James Hale. Our unique human immune cell models allow us to measure the immune modulating properties of these CCCM mixtures on the full complement of immune cell types.”.

Treatment 52

Treatment Research and Development Cannabinoids Data 52

TheAnswerPage

OCTOBER 11, 2021

Has the use of a transdermal gel for regional and systemic delivery of CBD been evaluated for the treatment of epilepsy? A transdermal gel for regional and systemic delivery of CBD (Zynerba Pharmaceuticals) is in clinical development for treatment of epilepsy, developmental and epileptic encephalopathy, fragile-X syndrome, and osteoarthritis.

Epilepsy 52

Epilepsy Topical Safety Treatment 52

Cannabis Law Report

DECEMBER 7, 2021

Scientific Reports volume 11 , Article number: 23462 ( 2021 ) Cite this article. Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Metrics details.

Safety 52

Safety Cannabinoids Events Data 52

The Blunt Truth

JANUARY 5, 2022

Below are some highlights of what happened in 2021. On June 22, 2021, Connecticut legalized recreational marijuana use by adults 21 years and older. On April 12, 2021, New Mexico saw the legalization of recreational marijuana. Now is no different. Connecticut. There are numerous positions and industries exempt from the law.

Law 105

Law Marijuana Policy Recreational 105

TheAnswerPage

OCTOBER 6, 2021

According to a JAMA Open Network article published in September 2021, in a “nonrandomized controlled trial, CBD transdermal gel was well tolerated over 6.5 months of treatment, with 60% of patients experiencing a treatment-related adverse event, 96% of which were mild or moderate. JAMA Netw Open. 2021;4(9):e2123930.

Sleep 52

Sleep Treatment Concentrates Safety 52

MMJ Recs

NOVEMBER 11, 2020

Which countries have been taking steps towards medical marijuana (MMJ) legalization that could potentially be finalized in 2021 or shortly after? This question is being asked by patients all over the world who would see a massive benefit in their quality of life if they could avail of medical marijuana treatment.

Legalization 52

Legalization Decriminalization Marijuana Epilepsy 52

Cannabis Law Report

JUNE 12, 2021

Road safety risks associated with medicinal cannabis appear similar or lower than numerous other potentially impairing prescription medications. Available online 6 June 2021. Here we undertake an analysis of this policy issue based on a case study of the introduction of medicinal cannabis in Australia. Conclusion.

Policy 66

Policy Safety Medicine Access 66

Cannabis Law Report

AUGUST 12, 2021

Net loss for the six months ended 30 June 2021 was $30.2 Net loss for the six months ended 30 June 2021 was $30.2 Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. On track to report top-line data by end of 2021.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

TheAnswerPage

OCTOBER 17, 2021

In September 2021, California Governor G. Newsom signed “Ryan’s Law” – legislation that expands end-of-life treatment options for Californians by requiring that hospitals and certain types of healthcare facilities in the state allow terminally-ill patients to use medical cannabis for treatment and/or pain relief.

Treatment 52

Treatment Patients Compliance Compliance 52

Veriheal

FEBRUARY 8, 2024

The NBA has been relaxing its prohibition against cannabis since 2021 when the league decided to end random drug testing for the substance. First-time offenders who tested positive for the drug were obligated to enter the basketball league’s substance-use treatment and counseling program.

Advocacy 112

Advocacy Chronic Pain Policy Cannabis 112

TheAnswerPage

OCTOBER 21, 2021

According to the European Pain Federation position paper on the appropriate use of cannabis-based medicines, “a testing period of maximum 3 months should be considered both by patients and prescribers [or recommenders], to assess treatment efficacy and safety. At the end of this testing period, long?term New accredited CME/CE courses.

Chronic Pain 59

Chronic Pain Treatment Therapy Safety 59

Cannabis Law Report

OCTOBER 15, 2021

At Kidney Week 2021, Goldfinch Bio will present multiple e-posters, including: The design of TRACTION-2, the ongoing Phase 2 clinical trial evaluating GFB-887 for the treatment of focal segmental glomerulosclerosis (FSGS) and diabetic nephropathy (DN). Presentations at ASN Kidney Week 2021, November 4-7, 2021.

Clinical Trials 52

Clinical Trials Research and Development Data Patients 52

Veriheal

DECEMBER 4, 2023

At that time, illicit substances were perceived as a significant threat to both workplace productivity and safety. According to 2021 research from the National Institutes of Health (NIH) , 18.7% Do not attempt to self-diagnose or prescribe treatment based on the information provided.

Policy 117

Policy Safety Treatment Business 117

Veriheal

NOVEMBER 28, 2023

The inaccuracy of impairment detection not only puts road safety at risk but also exposes innocent drivers to potential legal consequences. It requires striking a balance between adjusting to societal changes and ensuring public safety. Notably, a 2021 study conducted by Johns Hopkins University raised these concerns.

THC 113

THC Safety Treatment Legalization 113

TheAnswerPage

NOVEMBER 30, 2021

According to the CSA, schedule I substances have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. Psilocybin is actually a Schedule I substance under the Controlled Substances Act (CSA). THC is also a schedule I substance.)

Clinical Trials 52

Clinical Trials Safety Treatment THC 52

Cannabis Law Report

AUGUST 4, 2021

The Core Business delivered strong organic growth 13 in H1 2021 (17% year-on-year) despite some of Eurofins’ businesses remaining affected by lockdowns during H1 2021. The Core Business delivered strong organic growth 13 in H1 2021 (17% year-on-year) despite some of Eurofins’ businesses remaining affected by lockdowns during H1 2021.

Business 105

Business Research and Development Environment Food 105

Cannabis Law Report

JANUARY 3, 2022

Below are some highlights of what happened in 2021. On June 22, 2021, Connecticut legalized recreational marijuana use by adults 21 years and older. On April 12, 2021, New Mexico saw the legalization of recreational marijuana. Now is no different. Jennifer Mora. Connecticut. New Mexico. New Jersey.

Law 52

Law Marijuana Policy Recreational 52

TheAnswerPage

OCTOBER 18, 2021

“We do not regard cannabinoids as first-line treatments but as adjuvant therapies to be used before opioids if other options fail to control chronic non-cancer pain. We recommend selecting products verified for safety and potency by third-party testing.

Chronic Pain 52

Chronic Pain Therapy Cannabinoids Extraction 52

Veriheal

JANUARY 15, 2024

The 2023 World Drug Report shows unreasonable use of criminal penalties for the “war on drugs” movement as it discourages people who use drugs for treatment, and this encourages social stigma. In December 2021, Malta became the first European nation to legalize cannabis.

Policy 117

Policy Research and Development Collective Law 117

TheAnswerPage

NOVEMBER 23, 2021

According to a survey study that had enrolled just over 600 breast cancer patients, “almost half of all participants reported using cannabis during adjuvant or palliative radiation to relieve breast cancer symptoms or treatment side effects, most commonly: pain, insomnia, anxiety, stress, nausea/vomiting, and anorexia.

Chronic Pain 52

Chronic Pain Therapy Patients Safety 52

Cannabis Law Report

JUNE 12, 2021

Authors’ Abstract for Arkell, McCartney & McGregor (2021). Patients using THC-containing products should avoid driving and other safety-sensitive tasks (e.g., operating machinery), particularly during initiation of treatment and in the hours immediately following each dose. Arkell 2021 Med Cannab & GPs.

Patients 105

Patients THC Safety Treatment 105

Veriheal

NOVEMBER 10, 2020

The experiment will only last two years long and is set to start with the first prescription in March 2021. The post France Wants to Experiment With Giving Away Free Medical Cannabis in 2021 appeared first on Cannabis Central.

Chronic Pain 77

Chronic Pain Pharmaceutical Patients Epilepsy 77

Canna Law Blog

NOVEMBER 15, 2021

There was a fascinating panel on the use of ketamine treatments for, among other things, depression and anxiety disorders. Pharmaceutical start-ups are betting on the treatment potential of psychedelics. Coupled with the fact that , as of October 2021, 50 psychedelics companies are now publicly listed on U.S.

Clinical Trials 98

Clinical Trials Treatment Microdosing Pharmaceutical 98

Veriheal

AUGUST 16, 2023

In an unprecedented move that embraces the evolving landscape of sports health and wellness, the National Football League (NFL) has recently made a significant investment in cannabidiol (CBD) research, aiming to explore its potential as a pain treatment alternative for players suffering from concussions.

CBD 98

CBD Research and Development Treatment Policy 98

Cannabis Law Report

OCTOBER 29, 2021

NYSE American: IGC) announces its financial results for the three months ended September 30, 2021, which is the second quarter of the Company’s 2022 fiscal year. The primary endpoint of this Phase 1 trial was safety and tolerability. During the six months ended September 30, 2021, the Company raised approximately $4.1

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

Cannabis Law Report

DECEMBER 26, 2021

December 17, 2021 ·. – December 16, 2021) – Entheon Biomedical Corp. 63/283,051, titled “Detection of Therapeutic Psychedelic State,” as of November 23, 2021. 63/283,051, titled “Detection of Therapeutic Psychedelic State,” as of November 23, 2021. US Provisional Patent Filed.

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

TheAnswerPage

FEBRUARY 23, 2022

Some clinical studies have evaluated the safety and efficacy of cannabinoid-based medicines for the treatment of autism spectrum disorder (ASD). These adverse events were similar the adverse events in the trials examining the efficacy of CBD for the treatment of seizures. 17 Aug 2021. Fletcher S. See the Answer.

Clinical Trials 52

Clinical Trials Events Therapy Sleep 52

Cannabis Law Report

JUNE 25, 2021

DUBLIN–(BUSINESS WIRE)–The “Skin Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030” report has been added to ResearchAndMarkets.com’s offering. billion in 2021 at a compound annual growth rate (CAGR) of 11.8%. The global skin cancer drugs market is expected to grow from $1.44

Research and Development 84

Research and Development Therapy Pharmaceutical Clinical Trials 84

Cannabis Law Report

JUNE 2, 2021

As of May 2021, a majority of states allow for the medical use of marijuana. During the 2021 legislative session, the Idaho Legislature was presented with House Bill 108 , proposing to legalize medical marijuana. Epidiolex is a Schedule V controlled substance approved for the treatment of seizures. Idaho Code § 37-2701 et seq.

Law 103

Law Marijuana Oil Pharmaceutical 103

The Joint Blog

MARCH 21, 2021

CBD oil can be used in all sorts of ways, but it is most commonly associated with the treatment of various medical conditions. From the 31 st March 2021, all foods containing CBD must have been authorised and validated by the Food Standards Agency (FDA) as novel food products. CBD Safety. What is CBD oil used for?

Safety 26

Safety CBD Oil Cannabinoids 26

Cannabis Law Report

JUNE 4, 2021

– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. NEW YORK , June 4, 2021 /PRNewswire/ — AIkido Pharma Inc. Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021.

Data 100

Data Research and Development Clinical Trials Therapy 100

Canna Law Blog

DECEMBER 16, 2021

On Monday, November 13, 2021, New York Assemblyman Pat Burke introduced medical psilocybin legislation. Psilocybin research license, which will allow the testing potency, conducting clinical investigations, researching efficacy and safety, and agricultural research. Rules and Restrictions.

Legislation 96

Legislation Treatment Therapy Conditions 96

Cannabis Law Report

SEPTEMBER 23, 2021

This Was the World’s First Published Study Assessing MDMA-Assisted Psychotherapy as a Treatment for Addiction. Toronto, Ontario, Sep 23, 2021 (Newsfile Corp via COMTEX) — Toronto, Ontario–(Newsfile Corp. – September 23, 2021) – Awakn Life Sciences Corp., (NEO: Treatment of AUD rates are low at 16%.

Research and Development 52

Research and Development Therapy Treatment Data 52

Cannabis Law Report

FEBRUARY 17, 2022

WORCESTER – The Cannabis Control Commission (Commission) is alerting patients and consumers to its quarantine order (Order), issued October 18, 2021, mandating that ACK Natural, LLC, a colocated medical- and adult-use licensee, recall all products with unverifiable mycotoxin test results sold to its consumers and patients. Nantucket, MA.

Marijuana 52

Marijuana Seed-To-Sale Safety Patients 52

Cannabis Law Report

JANUARY 21, 2022

Our final 2021 looking back and looking forward episode. Doctors and patients consult with Liz on customizing cannabis treatment programs for various health problems that could benefit from the use of cannabis. Sit back relax and enjoy our guests mulling over the past, present & future. In order of appearance. Anthony Coniglio.

Research and Development 52

Research and Development Education Advocacy Policy 52

Cannabis Law Report

OCTOBER 22, 2021

–The Company expects to hold a Research & Development event to review,these breakthrough findings in Q4 2021 that will be open to the public, shareholders, analysts and the media– TORONTO, CANADA – October 19, 2021 – Cybin Inc.

Research and Development 52

Research and Development Safety Media Data 52